Eli Lilly and Company – Metastatic Breast Cancer

Submitted By:
Published Date:
January 25, 2020

Access Program Information

The treating physician/investigator contacts Lilly when, based on their medical opinion, a
patient meets the criteria for inclusion in the expanded access program.